Filing Details
- Accession Number:
- 0001209191-11-002346
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-01-06 19:05:33
- Reporting Period:
- 2011-01-04
- Filing Date:
- 2011-01-06
- Accepted Time:
- 2011-01-06 19:05:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
949858 | Oncogenex Pharmaceuticals Inc. | OGXI | In Vitro & In Vivo Diagnostic Substances (2835) | 954343413 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1442675 | Daniel Scott Cormack | 400-1001 W. Broadway Vancouver A1 V6H 4B1 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-01-04 | 6,608 | $3.89 | 19,675 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-01-04 | 6,608 | $16.52 | 13,067 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2011-01-04 | 3,392 | $3.89 | 11,484 | No | 4 | M | Indirect | Spouse |
Common Stock | Disposition | 2011-01-04 | 3,392 | $16.52 | 8,092 | No | 4 | S | Indirect | Spouse |
Common Stock | Acquisiton | 2011-01-05 | 8,660 | $3.89 | 21,727 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-01-05 | 8,660 | $0.00 | 13,067 | No | 4 | G | Direct | |
Common Stock | Acquisiton | 2011-01-05 | 8,660 | $0.00 | 44,340 | No | 4 | G | Indirect | By Trycor Investment Trust No. 1 |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Indirect | Spouse |
No | 4 | S | Indirect | Spouse |
No | 4 | M | Direct | |
No | 4 | G | Direct | |
No | 4 | G | Indirect | By Trycor Investment Trust No. 1 |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common | Stock Options | Disposition | 2011-01-04 | 6,608 | $0.00 | 6,608 | $3.89 |
Common | Stock Options | Disposition | 2011-01-04 | 3,392 | $0.00 | 3,392 | $3.89 |
Common | Stock Options | Disposition | 2011-01-05 | 8,660 | $0.00 | 8,660 | $3.89 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
8,660 | 2007-01-14 | 2011-01-14 | No | 4 | M | Direct |
0 | 2007-01-14 | 2011-01-14 | No | 4 | M | Indirect |
0 | 2007-01-14 | 2011-01-14 | No | 4 | M | Direct |
Footnotes
- Scott Cormack and his spouse are the trustees and beneficiaries of the Trycor Investment Trust No. 1
- These shares were exercised and sold under the 10b5 Sales Plan.
- These shares were exercised under the 10b5 Sales Plan.